Catalyst Wire Dossier Catalyst Wire Dossier

MORAb-022

· Morphotek
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MORAb-022, covering 2015-11-16 to 2015-11-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects [Phase 1]

See pricing